A top-5 pharma cut manual case processing by 60% with Reportum after a therapy launch.
A surge in adverse event reports after a launch made manual data entry and case booking unsustainable. The company deployed Reportum for structured direct reporting from patients, caregivers and clinicians across specialty pharmacy and patient support programs. The page reports a 60% reduction in manual case processing, better data accuracy and fewer follow-ups.
Qinecsa is a pharmacovigilance technology and services company, used by pharma to automate adverse event intake and run signal detection and safety operations
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Qinecsa on its own site — read the original case study on qinecsa.com ↗
Related use cases
- 01Aurinia replaced manual adverse event intake with Qinecsa's Reportum after launching LUPKYNIS.
- 02A Japanese healthcare group automated multilingual adverse event intake with Reportum.
- 03A top-10 pharma cut manual case handling by up to 80% with Reportum across 110 countries.
- 04A top-10 pharma unified safety signal detection across three business units on Qinecsa Vigilance Workbench.
- 05A pharma fixed pharmacovigilance gaps after critical EMA findings by moving to a new validated safety database.
- 06Transforming Content Operations for 2x Faster Time to Market